GSK’s TB vaccine makes a big step forward towards licensing

GSK’s TB vaccine makes a big step forward towards licensing

Source: 
Pharmaforum
snippet: 

GlaxoSmithKline has spent 20 years trying to develop an improved vaccine for tuberculosis, and new data for its lead candidate M72/AS01E suggests it is getting closer to a breakthrough in the disease.